semaglutide europe Suspected fake Ozempic puts several in hospital in Austria WHO warns of “harmful” fake

American Journal of Physiology - Heart and Circulatory Physiology, 298 (5), H1454H1465

The presence of obesity-related complications such as obstructive sleep apnea, metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD), or cardiovascular disease may justify longer treatment duration given the health benefits of sustained weight loss

To determine outliers the ROUT method was used and is based on the False Discovery Rate (FDR), specifying Q = 1%, which is the maximum desired FDR

There is no method to test potency at home, so adhering to the 28-day window is the only way to ensure dose accuracy